TME Pharma

TME Pharma, formerly NOXXON Pharma, is a Berlin-based clinical-stage biotechnology company developing RNA aptamer drug candidates for cancer and eye diseases. Its pipeline includes NOX-A12 and NOX-E36, and it operates through a virtual model using external consultants.